Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
2019 · Leukemia · 180 citations
https://doi.org/10.1038/s41375-019-0404-1
K
Kinga A. Kocemba‐Pilarczyk
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
766
Citations
12
h-index
18
i10-index
Kinga A. Kocemba‐Pilarczyk is an academic researcher from Jagiellonian University. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & Multiple Myeloma Research and Treatments & Wnt/β-catenin signaling in development and cancer. The author has an h-index of 12, co-authored 28 publications.
ORCID: 0000-0002-7119-2412Papers by this author
worksThe Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells
2023 · Pharmacological Reports · 97 citations
https://doi.org/10.1007/s43440-023-00504-1
Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease
2016 · Oncogene · 48 citations
https://doi.org/10.1038/onc.2016.368
The influence of PFK-II overexpression on neuroblastoma patients’ survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4
2019 · Cancer Cell International · 17 citations
https://doi.org/10.1186/s12935-019-1005-9
Analysis of Malignant Melanoma Cell Lines Exposed to Hypoxia Reveals the Importance of <i>PFKFB4</i> Overexpression for Disease Progression
2018 · Anticancer Research · 16 citations
https://doi.org/10.21873/anticanres.13044
The role of 6-phosphofructo-2-kinase (PFK-2)/fructose 2,6-bisphosphatase (FBPase-2) in metabolic reprogramming of cancer cells
2016 · Postępy Higieny i Medycyny Doświadczalnej · 14 citations
https://doi.org/10.5604/17322693.1218187
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat